Premium
Rapid quantitative determination of epirubicin and its metabolites in plasma using high performance liquid chromatography and fluorescence detection
Author(s) -
Dine T.,
Brunet C.,
Luyckx M.,
Cazin M.,
Gosselin P.,
Cazin J. L.
Publication year - 1990
Publication title -
biomedical chromatography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 65
eISSN - 1099-0801
pISSN - 0269-3879
DOI - 10.1002/bmc.1130040103
Subject(s) - chemistry , chromatography , epirubicin , high performance liquid chromatography , daunorubicin , fluorescence , pharmacokinetics , quantitative analysis (chemistry) , cartridge , cancer , pharmacology , leukemia , breast cancer , medicine , mechanical engineering , physics , quantum mechanics , engineering
A rapid sensitive and selective isocratic technique was developed for the analysis of plasma epirubicin and three of its known fluorescent metabolites epirubicinol, 4′‐ O ‐β‐D‐glucuronyl‐4′‐epidoxorubicin and 4′‐ O ‐β‐D‐glucuronyl 1,3‐dihydro‐4′‐epidoxorubicin, with daunorubicin as an internal standard, by using high performance liquid chromatography (HPLC) with fluorescence detection and a ‘Hypersil ODS’ column. The drugs were easily and efficiently extracted with a Sep‐Pak C 18 cartridge and the mean recoveries were greater than 85%. Intraassay and Interassay coefficients of variation (plasma samples) were better than 8.25%. An example of pharmacokinetic study obtained in a cancer patient after intravenous injection of epirubicine is described.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom